Rahika

Sobre este medicamento

Originator: Tabrecta by NOVARTIS · Manufacturer: Novartis Pharma. Indication & Dosage: Rahika (Capmatinib) is a prescription medicine used to treat metastatic non-small cell lung cancer (NSCLC). Capmatinib works by slowing or stopping the growth of cancer cells. Rahika manufactured by NOVARTIS. Capmatinib has to take orally twice daily with or without food. Side Effects: The most common side effects of Capmatinib are: Swelling hands/ankles/feet, tiredness, fever , nausea / vomiting , decreased appetite, weight loss, constipation, or diarrhea . The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.